Search Results - "Geft, D."

Desensitization in Mechanical Circulatory Support Patients Awaiting Heart Transplantation: What is the Post-Transplant Outcome? by Youn, J., Seguchi, O., Cole, R., Geft, D., Nishihara, K., Shen, A., Sharoff, R., Ramzy, D., Kobashigawa, J., Moriguchi, J.

“…Sensitization occurs with blood transfusions in recipients of left ventricular assist device (LVAD). 30% of LVAD patients develop a panel reactive antibody…”
Get full text

Desensitization Therapy for Mechanical Circulatory Support Patients with Existing Driveline Infection: Is It Safe with Current Desensitization Therapies? by Kittleson, M., Patel, J., Kransdorf, E., Shen, A., Nishihara, K., Rajkumar, S., Velleca, A., Geft, D., Czer, L., Moriguchi, J., Kobashigawa, J.

“…Patients with end-stage heart failure may undergo mechanical circulatory support (MCS) as a bridge to transplant. This strategy may be complicated by…”
Get full text

The Burden of Total Artificial Heart Patients and Complications after Heart Transplantation by Seguchi, O., Youn, J., Geft, D., Cole, R., Shen, A., Nishihara, K., Mersola, S., Runyan, C., Hajj, J., Ramzy, D., Kobashigawa, J.A., Moriguchi, J.

“…Increased perioperative risk has been observed in patients with left ventricular assist devices (LVAD) and total artificial hearts (TAH) undergoing heart…”
Get full text

Is Anti-Thymocyte Globulin for Sensitized Patients Undergoing Heart Transplantation Effective? by Kittleson, M., Patel, J., Kransdorf, E., Shen, A., Nishihara, K., Jamero, G., Sana, S., Hage, A., Geft, D., Czer, L., Esmailian, F., Kobashigawa, J.A.

“…Anti-thymocyte globulin (ATG) has been used as an induction agent in heart transplant (HTx). Early studies suggest that ATG can decrease de novo donor specific…”
Get full text

The Outcome of Heart Transplant Patients with Hemodynamic Compromise Rejection in the Current Era by Kobashigawa, J.A, Kittleson, M, Aintablian, T, Chang, D.H, Geft, D, Czer, L, Esmailian, F, Patel, J

Get full text

MCS Driveline Infections: Are They Truly Risk Factors for Poor Outcome? by Moriguchi, J, Czer, L, Henry, H, Jocson, R, Runyan, C, Aintablian, T, Passano, E, Chang, D, Geft, D, Arabia, F

Get full text

Outcome of Patients Proceeding to Heart Transplant with Low Level Donor-Specific Antibodies: How Do They Do? by Kittleson, M, Patel, J, Czer, L, Aintablian, T, Daun, T, Johnson, M, Chang, D, Trento, A, Geft, D, Kobashigawa, J.A

Get full text

Are Pediatric Donor Hearts Viable in Adult Recipients? by Kittleson, M, Patel, J, Czer, L, Aintablian, T, Rush, J, Johnson, M, Chang, D, Ramzy, D, Geft, D, Kobashigawa, J.A

Get full text

Coronary Vasospasm After Heart Transplantation: Does It Portend Poor Outcome? by Chang, D, Kittleson, M, Patel, J, Aintablian, T, Rodriguez, G, Levine, R, Geft, D, Kransdorf, E, Czer, L, Esmailian, F, Kobashigawa, J.A

Get full text

Correlation of the Grades of Antibody-Mediated Rejection to 1-Year IVUS Results After Heart Transplantation by Kobashigawa, J.A, Kittleson, M, Sana, S, Aintablian, T, Levine, R, Azarbal, B, Geft, D, Chang, D.H, Czer, L, Luthringer, D, Patel, J

Get full text

Does the New ISHLT Primary Graft Dysfunction (PGD) Grading Scale in Heart Transplantation Predict Outcome? by Patel, J, Kittleson, M, Aintablian, T, Levine, R, Curry, M, Hage, A, Geft, D, Chang, D, Czer, L, Ramzy, D, Kobashigawa, J.A

Get full text

Success for Combined Heart and Kidney Transplantation by Megna, D, Esmailian, F, Patel, J, Kittleson, M, Aintablian, T, Stimpson, E, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Kobashigawa, J.A

Get full text

Donor Heart Diastolic Dysfunction: Do You Take This Heart for Transplantation? by Liou, F, Kittleson, M, Patel, J, Aintablian, T, Kao, T, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Ramzy, D, Kobashigawa, J.A

Get full text

Treatment of Primary Graft Dysfunction with Plasmapheresis Improves Outcome by Chang, D.H, Kittleson, M, Patel, J, Aintablian, T, Levine, R, Geft, D, Kransdorf, E, Czer, L, Trento, A, Esmailian, F, Kobashigawa, J.A

Get full text

Only Persistent Donor Specific Antibodies are Associated with Subsequent Cardiac Allograft Vasculopathy After Heart Transplantation by Kobashigawa, J.A, Kittleson, M, Aintablian, T, Azarbal, B, Hage, A, Kransdorf, E, Geft, D, Chang, D, Czer, L, Esmailian, F, Zhang, X, Reinsmoen, N, Patel, J

Get full text

Is Tacrolimus/Proliferation Signal Inhibitor (PSI) Comparable to Cyclosporine/PSI After Heart Transplantation? by Chang, D, Kittleson, M, Patel, J, Aintablian, T, Velleca, A, Jamero, G, Kransdorf, E, Geft, D, Czer, L, Esmailian, F, Kobashigawa, J.A

Get full text

Donor Heart Turn Down in the Field: What’s Going On? by Patel, J, Kittleson, M, Aintablian, T, Kwan, J, Musto, N, Kearney, B, Geft, D, Chang, D.H, Czer, L, Esmailian, F, Kobashigawa, J.A

Get full text

Does Socioeconomic Status Impact Outcome Following Mechanical Circulatory Support Device Implantation? by Chang, D.H, Kittleson, M, Patel, J, Aintablian, T, Hamilton, M, Geft, D, Kransdorf, E, Czer, L, Kobashigawa, J.A, Arabia, F, Moriguchi, J

Get full text

Combined Heart-Kidney Transplant vs Heart Alone Transplant in Patients with Total Artificial Heart: Are they Viable? by Moriguchi, J, Kittleson, M, Patel, J, Aintablian, T, Kwan, J, Kransdorf, E, Geft, D, Chang, D.H, Czer, L, Kobashigawa, J.A, Arabia, F

Get full text

Side Effects of Proliferation Signal Inhibitors Limit Their Practical Use After Heart Transplantation by Chang, D.H, Kittleson, M, Patel, J, Aintablian, T, Arakawa, L, Jamero, G, Geft, D, Kransdorf, E, Czer, L, Ramzy, D, Kobashigawa, J.A

Get full text